AstraZeneca (LON:AZN) Given Sector perform Rating at Deutsche Bank Aktiengesellschaft

AstraZeneca (LON:AZN)‘s stock had its “sector perform” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a report issued on Tuesday,Digital Look reports. They presently have a £115 price target on the biopharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential downside of 1.99% from the stock’s current price.

AZN has been the subject of several other reports. Jefferies Financial Group reaffirmed a “buy” rating and set a £175 target price on shares of AstraZeneca in a research note on Monday. Citigroup increased their price objective on shares of AstraZeneca from £175 to £178 and gave the company a “buy” rating in a report on Tuesday, July 28th. Finally, Berenberg Bank restated a “buy” rating and set a £160 price objective on shares of AstraZeneca in a research report on Tuesday, July 28th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, AstraZeneca currently has an average rating of “Moderate Buy” and an average target price of £152.17.

AstraZeneca Trading Down 0.9%

AstraZeneca stock opened at £117.34 on Tuesday. AstraZeneca has a 1 year low of £107.84 and a 1 year high of £157.32. The firm’s 50 day moving average price is £133.56 and its 200-day moving average price is £140.06. The company has a debt-to-equity ratio of 64.10, a current ratio of 0.89 and a quick ratio of 0.59. The stock has a market cap of £181.98 billion, a P/E ratio of 17.67, a PEG ratio of 0.86 and a beta of 0.23.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.